Straus SE, Ostrove JM, Inchauspé G, Felser JM, Freifeld A,

Croen KD, et al. NIH conference. Varicella-zoster virus infections.

Biology, natural history, treatment, and prevention.

Ann Intern Med. 1988; 108(2):221-37. [DOI:10.7326/0003-

-108-2-221] [PMID]

Rimseliene G, Vainio K, Gibory M, Salamanca BV, Flem

E. Varicella-zoster virus susceptibility and primary healthcare

consultations in Norway. BMC Infect Dis. 2016; 16:254.

[DOI:10.1186/s12879-016-1581-4] [PMID] [PMCID]

Hyman RW, Ecker JR, Tenser RB. Varicella-zoster virus

RNA in human trigeminal ganglia. Lancet. 1983; 2(8354):814-

[DOI:10.1016/S0140-6736(83)90736-5] [PMID]

Sadzot-Delvaux C, Arvin AM, Rentier B. Varicella-zoster virus

IE63, a virion component expressed during latency and

acute infection, elicits humoral and cellular immunity. J Infect

Dis. 1998; 178 Suppl 1:S43-7. [DOI:10.1086/514259] [PMID]

Heininger U, Seward JF. Varicella. Lancet. 2006;

(9544):1365-76. [DOI:10.1016/S0140-6736(06)69561-5]

[PMID]

Morgan ER, Smalley LA. Varicella in immunocompromised

children. Incidence of abdominal pain and organ involvement.

Am J Dis Child. 1983; 137(9):883-5. [DOI:10.1001/archpedi.

02140350057014] [PMID]

Feldman S, Hughes WT, Daniel CB. Varicella in children

with cancer: Seventy-seven cases. Pediatrics. 1975; 56(3):388-

[DOI:10.1542/peds.56.3.388] [PMID]

Lee SJ, Chinen J, Kavanaugh A. Immunomodulator therapy:

Monoclonal antibodies, fusion proteins, cytokines, and immunoglobulins.

J Allergy Clin Immunol. 2010; 125(2 Suppl

:S314-23. [DOI:10.1016/j.jaci.2009.08.018] [PMID]

Kamar N, Milioto O, Puissant-Lubrano B, Esposito L,

Pierre MC, Mohamed AO, et al. Incidence and predictive

factors for infectious disease after rituximab therapy in kidney-

transplant patients. Am J Transplant. 2010; 10(1):89-98.

[DOI:10.1111/j.1600-6143.2009.02785.x] [PMID]

Scemla A, Loupy A, Candon S, Mamzer MF, Martinez F,

Zuber J, et al. Incidence of infectious complications in highly

sensitized renal transplant recipients treated by rituximab: A

case-controlled study. Transplantation. 2010; 90(11):1180-4.

[DOI:10.1097/TP.0b013e3181fa941b] [PMID]

Kasi PM, Tawbi HA, Oddis CV, Kulkarni HS. Clinical review:

Serious adverse events associated with the use of rituximab

- a critical care perspective. Crit Care. 2012; 16(4):231.

[DOI:10.1186/cc11304] [PMID] [PMCID]

Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology

of varicella and its complications. J Infect Dis . 1995;

(3):706-12. [DOI:10.1093/infdis/172.3.706] [PMID]

Nixon A, Ogden L, Woywodt A, Dhaygude A. Infectious

complications of rituximab therapy in renal disease. Clin Kidney

J. 2017; 10(4):455-60. [DOI:10.1093/ckj/sfx038] [PMID]

[PMCID]

Ulinski T, Sellier-Leclerc AL, Tudorache E, Bensman A,

Aoun B. Acute tubulointerstitial nephritis. Pediatr Nephrol.

; 27(7):1051-7. [DOI:10.1007/s00467-011-1915-9] [PMID]

Bastard P, Galerne A, Lefevre-Utile A, Briand C, Baruchel

A, Durand P, et al. Different clinical presentations and outcomes

of disseminated varicella in children with primary

and acquired immunodeficiencies. Front Immunol. 2020;

:595478. [DOI:10.3389/fimmu.2020.595478] [PMID] [PMCID]

Müller I, Aepinus C, Beck R, Bültmann B, Niethammer D,

Klingebiel T. Noncutaneous varicella-zoster virus (VZV) infection

with fatal liver failure in a child with acute lymphoblastic

leukemia (ALL). Med Pediatr Oncol. 2001; 37(2):145-7.

[DOI:10.1002/mpo.1186] [PMID]

Kuwano K, Ota Y, Tsuji K, Torigoe K, Yamashita A, Muta

K, et al. An autopsy case of disseminated varicella zoster virus

infection during the treatment of nephrotic syndrome.

Intern Med. 2022; 61(4):571-6. [DOI:10.2169/internalmedicine.

-21] [PMID] [PMCID]

Sinha A, Bagga A. Rituximab therapy in nephrotic syndrome:

Implications for patients' management. Nat Rev

Nephrol. 2013; 9(3):154-69. [DOI:10.1038/nrneph.2012.289]

[PMID]